ArticleExperimental & molecular medicine2026
The inhibition of lactate/Gpr81 signalling driven by moderate-intensity continuous training protects against osteoarthritis.
Article in Experimental & molecular medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
Abstract
Osteoarthritis (OA) is among the most prevalent chronic diseases worldwide. However, currently employed pharmacological therapies for OA are associated with various reported side effects. Exercise therapy represents a potentially safer and more effective strategy for OA treatment, although its underlying mechanism remains unclear. Here, we demonstrate that compared with high-intensity continuous training, moderate-intensity continuous training (MICT) has greater therapeutic potential for OA. Notably, these beneficial effects of MICT were abrogated following gut microbiota depletion. Moreover, transplantation of the gut microbiota from MICT-treated mice inhibited OA progression. Akkermansia was identified as the most significantly altered microbiota in response to MICT, and supplementation with Akkermansia in destabilization of the medial meniscus mice also alleviated OA. Mechanistically, MICT protects against OA by reducing plasma lactate levels. Production of high levels of lactate by numerous microbiotas was identified as a risk factor induced by destabilization of the medial meniscus. Consistent with these findings, our genetic data revealed that both the knockout of the lactate receptor Gpr81 and the knockdown of Gpr81 in articular cartilage with adeno-associated virus 2 mitigated OA progression by increasing anabolic metabolism and suppressing catabolic metabolism. The Gαi-CREB/NF-κB axis was further identified as the primary downstream pathway mediating the biological effects of Gpr81 in chondrocytes. Clinically, we validated a negative correlation between Akkermansia abundance and both synovial fluid lactate levels and GPR81 expression in the articular cartilage of OA patients. Collectively, the results of this study not only reveal the mechanism underlying the protective effects of exercise against OA but also identify a novel therapeutic target for OA treatment. Moderate-intensity continuous training remodelled the gut microbial composition in destabilization of the medial meniscus mice, which in turn decreased blood lactate levels, further alleviated destabilization of the medial meniscus-induced hyper-lactate and Gpr81 overactivation, ultimately ameliorating osteoarthritis by coordinating the Gαi-CREB/NF-κB signalling pathway.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.